日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development and Validation of a Scaffold-Free Human Multilineage Spheroid Model for Early Stage Cholangiopathies Driven by Cholangiocyte Senescence

构建和验证一种无支架的人类多系球状体模型,用于研究胆管细胞衰老驱动的早期胆管疾病

Wu, Cheuk-Ting; Moncsek, Anja; Mertens, Joachim

Effect of Direct Acting Antiviral Drugs on the Occurrence and Recurrence of Intra- and Extra-Hepatic Malignancies in Patients with Chronic Hepatitis C Virus Infection

直接抗病毒药物对慢性丙型肝炎病毒感染患者肝内和肝外恶性肿瘤发生及复发的影响

Radu, Pompilia; Becchetti, Chiara; Schropp, Jonas; Schmid, Patrick; Künzler-Heule, Patrizia; Mertens, Joachim; Moradpour, Darius; Müllaupt, Beat; Semela, David; Negro, Francesco; Heim, Markus; Clerc, Olivier; Roelens, Maroussia; Keiser, Olivia; Berzigotti, Annalisa; Swiss Hepatitis C Cohort Study

Evaluation of soluble suppression of tumorigenicity 2 (sST2) as serum marker for liver fibrosis

可溶性肿瘤抑制因子2 (sST2) 作为肝纤维化血清标志物的评价

Hildenbrand, Florian F; Illi, Barbara; von Felten, Stefanie; Bachofner, Jacqueline; Gawinecka, Joanna; von Eckardstein, Arnold; Müllhaupt, Beat; Mertens, Joachim C; Blümel, Sena

Monitoring the SARS-CoV-2 pandemic: screening algorithm with single nucleotide polymorphism detection for the rapid identification of established and emerging variants

监测SARS-CoV-2疫情:利用单核苷酸多态性检测快速识别已发现和新出现的变异株的筛查算法

Mertens, Joachim; Coppens, Jasmine; Loens, Katherine; Le Mercier, Marie; Xavier, Basil Britto; Lammens, Christine; Vandamme, Sarah; Jansens, Hilde; Goossens, Herman; Matheeussen, Veerle

Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?

羧肽酶 U (CPU, TAFIa, CPB2) 在血栓栓塞性疾病中的作用:发现三十年后,我们了解了什么?

Claesen, Karen; Mertens, Joachim C; Leenaerts, Dorien; Hendriks, Dirk

Rates of Hepatocellular Carcinoma After Start of Treatment for Chronic Hepatitis C Remain High with Direct Acting Antivirals: Analysis from a Swiss Liver Transplant Center

瑞士肝移植中心的一项分析显示,使用直接抗病毒药物治疗慢性丙型肝炎后,肝细胞癌的发生率仍然很高:

Karbeyaz, Fatih; Kissling, Seraphina; Jaklin, Paul Julius; Bachofner, Jaqueline; Brunner, Barbara; Müllhaupt, Beat; Winder, Thomas; Mertens, Joachim C; Misselwitz, Benjamin; von Felten, Stefanie; Siebenhüner, Alexander R

Cholangiocarcinoma 2020: the next horizon in mechanisms and management

2020年胆管癌:机制和治疗的新进展

Banales, Jesus M; Marin, Jose J G; Lamarca, Angela; Rodrigues, Pedro M; Khan, Shahid A; Roberts, Lewis R; Cardinale, Vincenzo; Carpino, Guido; Andersen, Jesper B; Braconi, Chiara; Calvisi, Diego F; Perugorria, Maria J; Fabris, Luca; Boulter, Luke; Macias, Rocio I R; Gaudio, Eugenio; Alvaro, Domenico; Gradilone, Sergio A; Strazzabosco, Mario; Marzioni, Marco; Coulouarn, Cédric; Fouassier, Laura; Raggi, Chiara; Invernizzi, Pietro; Mertens, Joachim C; Moncsek, Anja; Ilyas, Sumera I; Heimbach, Julie; Koerkamp, Bas Groot; Bruix, Jordi; Forner, Alejandro; Bridgewater, John; Valle, Juan W; Gores, Gregory J

Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma.

血小板衍生生长因子-D 可使肝脏肌成纤维细胞促进胆管癌中的肿瘤淋巴管生成

Cadamuro Massimiliano, Brivio Simone, Mertens Joachim, Vismara Marta, Moncsek Anja, Milani Chiara, Fingas Christian, Cristina Malerba Maria, Nardo Giorgia, Dall'Olmo Luigi, Milani Eleonora, Mariotti Valeria, Stecca Tommaso, Massani Marco, Spirli Carlo, Fiorotto Romina, Indraccolo Stefano, Strazzabosco Mario, Fabris Luca

The tumour microenvironment and immune milieu of cholangiocarcinoma

胆管癌的肿瘤微环境和免疫微环境

Fabris, Luca; Perugorria, María J; Mertens, Joachim; Björkström, Niklas K; Cramer, Thorsten; Lleo, Ana; Solinas, Antonio; Sänger, Hanna; Lukacs-Kornek, Veronika; Moncsek, Anja; Siebenhüner, Alexander; Strazzabosco, Mario

Cell Interactions in Biliary Diseases: Clues from Pathophysiology and Repair Mechanisms to Foster Early Assessment

胆道疾病中的细胞相互作用:从病理生理学和修复机制中寻找线索以促进早期评估

Fabris, Luca; Spirli, Carlo; Mertens, Joachim